Javascript must be enabled to continue!
Additional balloon aortic valvuloplasty to overcome the difficult removal of a self‐expandable transcatheter aortic valve system due to valve infolding
View through CrossRef
AbstractTranscatheter aortic valve replacement (TAVR) is a well‐established treatment for severe aortic stenosis. Advances in the devices used and operators' technique have reduced the frequency of complications. However, valve infolding is a rare but serious outcome after the implantation of self‐expanding prostheses. We report a case of a successful bailout of a device that was difficult to remove because of valve infolding. TAVR using a 26 mm Evolut PRO+ system (Medtronic) was planned for a 91‐year‐old woman with severe aortic stenosis. After the valve was deployed in a satisfactory position on the second release, the system could not be removed because the nose cone was hooked to the basal frame of the deployed valve. To overcome this situation, an additional balloon was inserted from the contralateral femoral side and inflated, and we extracted the system successfully by pulling out the device while simultaneously deflating the balloon. Postoperative computed tomography revealed valve infolding, which was considered to cause the difficulty in system removal. Infoldings of self‐expandable prostheses should be considered when faced with difficulty in removing the catheter system, and the method elucidated in this case report can be effective to manage it.
Title: Additional balloon aortic valvuloplasty to overcome the difficult removal of a self‐expandable transcatheter aortic valve system due to valve infolding
Description:
AbstractTranscatheter aortic valve replacement (TAVR) is a well‐established treatment for severe aortic stenosis.
Advances in the devices used and operators' technique have reduced the frequency of complications.
However, valve infolding is a rare but serious outcome after the implantation of self‐expanding prostheses.
We report a case of a successful bailout of a device that was difficult to remove because of valve infolding.
TAVR using a 26 mm Evolut PRO+ system (Medtronic) was planned for a 91‐year‐old woman with severe aortic stenosis.
After the valve was deployed in a satisfactory position on the second release, the system could not be removed because the nose cone was hooked to the basal frame of the deployed valve.
To overcome this situation, an additional balloon was inserted from the contralateral femoral side and inflated, and we extracted the system successfully by pulling out the device while simultaneously deflating the balloon.
Postoperative computed tomography revealed valve infolding, which was considered to cause the difficulty in system removal.
Infoldings of self‐expandable prostheses should be considered when faced with difficulty in removing the catheter system, and the method elucidated in this case report can be effective to manage it.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Valvuloplasty Balloon Catheter Sizing Approach for Calcified Aortic Valve with Different Annulus Ratios
Valvuloplasty Balloon Catheter Sizing Approach for Calcified Aortic Valve with Different Annulus Ratios
Transcatheter aortic valve implantation (TAVI) is re- garded as the option of preference minimally invasive intervention to treat high-risk patients with aortic steno- sis, whic...
Abstract 4145264: Balloon-expandable versus Self-expandable transcatheter aortic valve replacement for failed surgical prostheses: A systematic review and meta-analysis
Abstract 4145264: Balloon-expandable versus Self-expandable transcatheter aortic valve replacement for failed surgical prostheses: A systematic review and meta-analysis
Background:
Transcatheter aortic valve-in-valve (VIV) replacement has emerged as a valid alternative to conventional re-operation for the treatment of failed bioprosthe...
The Critical Role of Presettable and Expandable Artificial Surgical Valves in the Lifetime Management of Valvular Heart Disease
The Critical Role of Presettable and Expandable Artificial Surgical Valves in the Lifetime Management of Valvular Heart Disease
With the trend of younger patients undergoing surgical valve replacement and increased life expectancy, how to account for subsequent therapies during the initial valve replacement...
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Abstract
Background
Surgical aortic valve replacement has been the treatment of choice for patients with aortic valve disease be...
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Abstract 4369914: Successful Transfemoral TAVR in a Patient with Chronic Aortic Dissection and Severe Aortic Insufficiency
Abstract 4369914: Successful Transfemoral TAVR in a Patient with Chronic Aortic Dissection and Severe Aortic Insufficiency
Transcatheter aortic valve replacement is a well-established treatment for high-surgical-risk patients with severe aortic disease, providing a less invasive alternative to traditio...
Leaflet Resection Improves Valve Expansion and Hemodynamic Performance in Redo TAVI with Balloon- and Self-Expanding Valve-in-Valve Configurations
Leaflet Resection Improves Valve Expansion and Hemodynamic Performance in Redo TAVI with Balloon- and Self-Expanding Valve-in-Valve Configurations
Redo transcatheter aortic valve implantation (redo-TAVI) is increasingly carried out to treat degenerated transcatheter heart valves. Residual calcified leaflet tissue from the fir...

